4
Changes in Ownership
TEVA PHARMACEUTICAL INDUSTRIES LTD Filed Acc 0001209191-22-017066
Chief Accounting Officer acquired 5,967 shares (option exercise)
From the SEC's structured data for this filing
Trades in this filing
Weiss Amir · Chief Accounting Officer
Table I: Non-derivative
2 lines| Date | Transaction | Shares | Owned after | D/I |
|---|---|---|---|---|
| 2022-03-04 | Exercise or conversion : show line 1 in the form | +2,403 | 20,994.41 | D |
| 2022-03-05 | Exercise or conversion : show line 2 in the form | +3,564 | 24,558.41 | D |
Table II: Derivative
3 lines| Date | Transaction | Shares | Owned after | D/I |
|---|---|---|---|---|
| 2022-03-04 | Exercise or conversion : show line 3 in the form Restricted Share Units | −2,403 | 2,406 | D |
| 2022-03-04 | Grant or award : show line 4 in the form Restricted Share Units | +42,707 | 42,707 | D |
| 2022-03-05 | Exercise or conversion : show line 5 in the form Restricted Share Units | −3,564 | 10,694 | D |
Loading xslF345X03/doc4.xml…